نتایج جستجو برای: ctscan dose profile

تعداد نتایج: 521031  

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2014
Vincent Ribrag Jehan Dupuis Herve Tilly Franck Morschhauser Fabrice Laine Roch Houot Corinne Haioun Christiane Copie Andrea Varga John Lambert Laurence Hatteville Samira Ziti-Ljajic Anne Caron Sandrine Payrard Bertrand Coiffier

PURPOSE To determine recommended dose, dose-limiting toxicity, safety profile, pharmacokinetics, preliminary antitumor activity, and exploratory pharmacodynamics of SAR3419, an antibody-drug conjugate targeting CD19, administered alone by intravenous infusion weekly (qw), in a dose-escalation phase I study in patients with refractory/relapsed (R/R) non-Hodgkin lymphoma (NHL). EXPERIMENTAL DES...

Journal: :Acta oncologica 2006
J J Nuyttens J-B Prévost J Praag M Hoogeman R J Van Klaveren P C Levendag P M T Pattynama

Lung tumor tracking during stereotactic radiotherapy with the CyberKnife requires the insertion of markers in or close to the tumor. To reduce the risk of pneumothorax, three methods of marker placement were used: 1) intravascular coil placement, 2) percutaneous intrathoracal, and 3) percutaneous extrathoracal placement. We investigated the toxicity of marker placement and the tumor response of...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2007
Paul Haluska Heather M Shaw Gretchen N Batzel Donghua Yin Julian R Molina L Rhoda Molife Timothy A Yap M Luisa Roberts Amarnath Sharma Antonio Gualberto Alex A Adjei Johann S de Bono

PURPOSE This phase I study was undertaken to define the maximum tolerated dose, safety, and pharmacokinetic profile of CP-751,871. EXPERIMENTAL DESIGN Using a rapid dose escalation design, patients with advanced nonhematologic malignancies were treated with CP-751,871 in four dose escalation cohorts. CP-751,871 was administered i.v. on day 1 of each 21-day cycle. Pharmacokinetic evaluation wa...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2011
Danny Rischin David C Bibby Geoff Chong Gabriel Kremmidiotis Annabell F Leske Clayton A Matthews Shirley S Wong Mark A Rosen Jayesh Desai

PURPOSE To determine the recommended phase II dose and evaluate the safety and toxicity profile and pharmacokinetic (PK) and pharmacodynamic (PD) effects of BNC105P, an inhibitor of tubulin polymerization that has vascular disrupting and antiproliferative effects. EXPERIMENTAL DESIGN BNC105P was administered as a 10-minute infusion on days 1 and 8 of a 21-day cycle in a first-in-human phase I...

2011
Volker Wacheck Michael Lahn Gemma Dickinson Wolfgang Füreder Renata Meyer Susanne Herndlhofer Thorsten Füreder Georg Dorfner Sada Pillay Valérie André Timothy P Burkholder Jacqueline K Akunda Leann Flye-Blakemore Dirk Van Bockstaele Richard F Schlenk Wolfgang R Sperr Peter Valent

BACKGROUND Acute myeloid leukemia (AML) is a life-threatening malignancy with limited treatment options in chemotherapy-refractory patients. A first-in-human dose study was designed to investigate a safe and biologically effective dose range for LY2457546, a novel multikinase inhibitor, in patients with relapsed AML. METHODS In this nonrandomized, open-label, dose escalation Phase I study, LY...

2006
Sergey Kriminski Alex N. Li Timothy D. Solberg

Respiratory gated radiotherapy may allow reduction of the treatment margins, thus sparing healthy tissue and/or allowing dose escalation to the tumor. However, current commissioning and quality assurance of linear accelerators do not include evaluation of gated delivery. The purpose of this study is to test gated photon delivery of a Siemens ONCOR Avant-Garde linear accelerator. Dosimetric char...

2013
Wenli Zhang Martin Muck-Hausl Jichang Wang Chuanbo Sun Maren Gebbing Csaba Miskey Zoltan Ivics Zsuzsanna Izsvak Anja Ehrhardt

We recently developed adenovirus/transposase hybrid-vectors utilizing the previously described hyperactive Sleeping Beauty (SB) transposase HSB5 for somatic integration and we could show stabilized transgene expression in mice and a canine model for hemophilia B. However, the safety profile of these hybrid-vectors with respect to vector dose and genotoxicity remains to be investigated. Herein, ...

Journal: :Cosmoderma 2021

Low-dose oral minoxidil (OM) has increasingly been used by many doctors around the world as a treatment option for hair loss. Sufficient data regarding its effect and side profile are lacking. An online search was done on PUBMED GOOGLE SCHOLAR articles that OM Doses ranging from 0.25 to 5 mg have in various studies. Good compliance tolerability noticed with low-dose therapy. Adverse effects few...

Mohadese Razavian Mohammadhassan Ghosian Moghaddam Yaser Masomi

Background and Objective: Alleviation of serum glucose level and lipid profile in diabetic patients using herbal medications is of great importance. In the present study, the effect of oral consumption of olive leaves on serum glucose level and lipid profile was investigated. Materials and Methods: Male Wistar rats were divided into four groups including control, control under treatment, diabet...

Background and objectives: Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease caused by the accumulation of large amounts of fat in the hepatocytes. Given that atorvastatin is effective for treatment of NAFLD, the present study investigated effects of high-fat/fructose diet (HFFD) with atorvastatin on liver enzymes and lipid profile in a NAFLD rat model. Methods: Thirty-two m...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید